Protide HealthIn stock
Hexarelin · 3 mg × 1 vial
$55.00$18.33 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
Hexarelin research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 3 mg × 1 vial$18.33 / mg · $55.00Protide Health · checked 5 days ago
Listings at 3 mg × 1 vial
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Protide Health | 3 mg × 1 vial | $55.00 | $18.33 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
By size
Every package size we track for Hexarelin. Current means seen in the last 8 days.
| 2 mg × 1 vial | $21.56 | $10.78 / mg | 1 / 1 | 1 |
|---|---|---|---|---|
| 3 mg × 1 vial | $55.00 | $18.33 / mg | 1 / 1 | 1 |
| 5 mg × 1 vial | $45.00 | $9.00 / mg | 3 / 3 | 3 |
| 10 mg × 1 vial | $89.00 | $8.90 / mg | 1 / 1 | 1 |
| 2 mg × 10 vials | — | — | 0 / 1 | 0 |
| 10 mg × 10 vials | $799.00 | $7.99 / mg | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- Not in any 503A category on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- No PCAC meeting on hexarelin found on FDA's 2022 to 2027 PCAC meeting pages (checked 2026-11-03)Checked
- Rulemaking / enforcement
- No FDA document found in the Federal Register (search on 2026-11-03); the only matches are FTC notices on the horseracing anti-doping ruleChecked
- WADA
- S2.2.4 Growth hormone releasing factors: GH-releasing peptides (GHRPs) · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
- Identity
- Formula C47H58N12O6 · MW 887.0 g/mol · CAS 140703-51-1Sequence His-D-Trp(2-Me)-Ala-Trp-D-Phe-Lys-NH2Source record Checked
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.